Advisor Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Advisor Partners's RGEN Position: Q2 2022 in Review
Advisor Partners increased its Repligen (RGEN) stake by 28% in Q2 2022, buying an estimated $54.4K and bringing the position to 1,577 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #695.
Advisor Partners first reported a position in RGEN in Q4 2020 and has held it in 7 quarters since. The position peaked at $292K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.
- Advisor Partners held 1,577 shares of Repligen worth $256K as of Q2 2022.
- Advisor Partners bought 344 Repligen shares in Q2 2022, an estimated $54.4K.
- Repligen made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #695 holding.
- Advisor Partners first reported a position in Repligen in Q4 2020 and has held it in 7 quarters since.
- Advisor Partners's Repligen position peaked at $292K in Q3 2021.
- 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.